$1.42
0.0241.71%
Últ. Act.: Nov 6, 7:33 PM
The average analyst price target for Enveric Biosciences is $120, 8410.6% above the current price. The one analyst covering it rates it Buy. The latest change came on Jan 30, 2024, when HC Wainwright & Co. initiated coverage of Enveric Biosciences with a Buy rating and a $1,800 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months